/INTEG-B.ST
INTEG-B.ST Stock - Integrum AB (publ)
Healthcare|Medical - DevicesSTO
$10.06-0.79%
$0.08 (-0.79%) • Dec 23
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.32
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.90
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $11.07
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INTEG-B.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$9.96 – $10.16
TARGET (TP)$11.57
STOP LOSS$9.26
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.75
52W High$43.15
52W Low$8.02
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $91.10M | $104.12M | $74.27M | $55.72M | $43.09M |
| Gross Profit | $75.38M | $91.26M | $60.84M | $46.56M | $34.89M |
| Gross Margin | 82.7% | 87.7% | 81.9% | 83.6% | 81.0% |
| Operating Income | $-42,375,000 | $6.51M | $-19,704,443 | $1.04M | $-1,852,432 |
| Net Income | $-30,852,000 | $4.03M | $-16,181,566 | $21.27M | $-2,140,536 |
| Net Margin | -33.9% | 3.9% | -21.8% | 38.2% | -5.0% |
| EPS | $-1.45 | $0.23 | $-0.88 | $1.20 | $-0.14 |
Company Overview
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. The company also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was founded in 1962 and is headquartered in Mölndal, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
INTEG-B.STBeat Rate
29%
Last 7 quarters
Avg Surprise
-268.9%
EPS vs Estimate
Beats / Misses
2/5
Last 12 quarters
Latest EPS
$-0.34
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
+99.2%
$0.12vs$0.06
Q3 24
-1030.0%
$-0.46vs$0.05
Q4 24
-18.3%
$-0.46vs$-0.39
Q1 25
+53.9%
$-0.18vs$-0.39
Q2 25
-40.6%
$-0.42vs$-0.30
Q3 25
-186.3%
$-0.46vs$-0.16
Q4 25
-760.4%
$-0.34vs$-0.04
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 13, 2025 | $-0.04 | $-0.34 | -760.4% | ✗ MISS |
Q3 2025 | Sep 1, 2025 | $-0.16 | $-0.46 | -186.3% | ✗ MISS |
Q2 2025 | Jun 3, 2025 | $-0.30 | $-0.42 | -40.6% | ✗ MISS |
Q1 2025 | Feb 18, 2025 | $-0.39 | $-0.18 | +53.9% | ✓ BEAT |
Q4 2024 | Dec 4, 2024 | $-0.39 | $-0.46 | -18.3% | ✗ MISS |
Q3 2024 | Aug 29, 2024 | $0.05 | $-0.46 | -1030.0% | ✗ MISS |
Q2 2024 | May 30, 2024 | $0.06 | $0.12 | +99.2% | ✓ BEAT |
Q1 2024 | Feb 29, 2024 | — | $0.04 | — | — |
Q4 2023 | Dec 4, 2023 | — | $0.21 | — | — |
Q3 2023 | Aug 31, 2023 | — | $-0.16 | — | — |
Q2 2023 | Jun 8, 2023 | — | $-0.33 | — | — |
Q1 2023 | Mar 1, 2023 | — | $-0.74 | — | — |
Q4 2022 | Dec 1, 2022 | — | $0.13 | — | — |
Q3 2022 | Aug 31, 2022 | — | $-0.03 | — | — |
Q2 2022 | Jun 10, 2022 | — | $0.21 | — | — |
Q1 2022 | Mar 2, 2022 | — | $0.03 | — | — |
Q4 2021 | Dec 2, 2021 | — | $0.89 | — | — |
Q3 2021 | Sep 2, 2021 | — | $0.07 | — | — |
Q2 2021 | May 31, 2021 | — | $0.02 | — | — |
Q2 2021 | Apr 30, 2021 | — | $-0.14 | — | — |
Latest News
Loading news...
Frequently Asked Questions about INTEG-B.ST
What is INTEG-B.ST's current stock price?
Integrum AB (publ) (INTEG-B.ST) is currently trading at $10.06 per share. The stock has moved -0.79% today.
What is the analyst price target for INTEG-B.ST?
No analyst price targets are currently available for this stock.
What sector is Integrum AB (publ) in?
Integrum AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is INTEG-B.ST's market cap?
Integrum AB (publ) has a market capitalization of $0.21 billion, making it a small-cap company.
Does INTEG-B.ST pay dividends?
No, Integrum AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorALZ.ST
Alzinova AB (publ)
$0.82
Mkt Cap: $0.1B
ANNX.ST
Annexin Pharmaceuticals AB (publ)
$19.00
Mkt Cap: $0.1B
BRAIN.ST
BrainCool AB (publ)
$0.58
Mkt Cap: $0.1B
CLS-B.ST
Clinical Laserthermia Systems AB (publ)
$7.00
Mkt Cap: $0.2B
ERMA.ST
Enorama Pharma AB (publ)
$2.30
Mkt Cap: $0.2B
IZAFE-B.ST
iZafe Group AB (publ)
$0.47
Mkt Cap: $0.1B
KLAR.ST
Klaria Pharma Holding AB (publ.)
$0.61
Mkt Cap: $0.2B
NEOLA.ST
Neola Medical AB (publ)
$1.11
Mkt Cap: $0.1B
NOSA.ST
Nosa Plugs AB
$0.62
Mkt Cap: $0.2B
QLINEA.ST
Q-linea AB (publ)
$22.36
Mkt Cap: $0.1B
Explore stocks similar to INTEG-B.ST for comparison